Pentamaster diversifying into medical device business


Pentamaster chairman CB Chuah (pic) told StarBiz that the group was now in the process of submitting application to get approvals from the US-based Food & Drugs Agency (FDA) and Malaysian Drug Agency (MDA) for the business.

GEORGE TOWN: Semiconductor test equipment maker Pentamaster Corp Bhd is investing over RM100mil over the next three years in a medical device plant as the company seeks to diversify into the medical device business to broaden its revenue base.

Group chairman CB Chuah told StarBiz that the group was now in the process of submitting application to get approvals from the US-based Food & Drugs Agency (FDA) and Malaysian Drug Agency (MDA) for the business.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Ringgit closes higher against greenback on cautious market sentiment
T7 Global subsidiary appointed panel contractor for PETRONAS
YTL inks RM200mil naming rights deal with Aviva for Bristol arena
KL High Court dismisses appeals of former Jalatama officers
Well Chip posts FY25 net profit jump to RM86.15mil
Angkasa targets 2026 revenue to reach up to RM75bil
Aeon Credit issues RM100mil five-year senior sukuk
Late bargain-hunting lifts Bursa Malaysia to end higher
Net foreign inflows into Malaysian bonds reach RM951.9mil in January - RAM Ratings
Wawasan Dengkil's 2Q net profit falls due to revision of project costs

Others Also Read